神经炎症
神经保护
莫里斯水上航行任务
小胶质细胞
海马体
促炎细胞因子
微量注射
海马结构
记忆障碍
神经科学
细胞凋亡
医学
认知障碍
药理学
化学
心理学
免疫学
内科学
炎症
疾病
认知
生物化学
作者
Gangling Chen,Caihong Liu,Guoliang Meng,Chunteng Zhang,Fang Chen,Susu Tang,Hao Hong,Chaofeng Zhang
摘要
Objectives Cognitive impairment is the main character of Alzheimer's disease (AD). This study mainly focused on whether mogrol, a tetracyclic triterpenoids compound of Siraitia grosvenorii Swingle, can ameliorate the memory impairment induced by Aβ1–42. Methods Memory impairment mice model was made by stereotactic intra-hippocampal microinjection of Aβ1–42 (410 pm/mouse). Mogrol (20, 40, 80 mg/kg) was given to mice by intragastric administration at 3 days after Aβ1–42 injection for totally 3 weeks. Morris water maze test and Y-maze test were operated to evaluate the therapeutic effect of morgrol on Aβ1–42-induced memory impairments. Immunohistochemical analyses and Hoechst 33258 assay were used to evaluate effect of morgrol on Aβ1–42-induced microglia overactivation and apoptotic response in hippocampus of mice. Western blotting assay was used to evaluate effect of mogrol on the Aβ1–42-activated NF-κB signaling. Key findings Mogrol could significantly alleviate Aβ1–42-induced memory impairments, inhibit Aβ1–42-induced microglia overactivation and prevent Aβ1–42-triggered apoptotic response in the hippocampus. Mogrol also could suppress Aβ1–42-activated NF-κB signaling, reduce the production of proinflammatory cytokines. Conclusions This study suggested that mogrol would ameliorate the memory impairment induced by Aβ1–42, which is involved in anti-inflammation and anti-apoptosis in the brain.
科研通智能强力驱动
Strongly Powered by AbleSci AI